$661 Million is the total value of Rhenman & Partners Asset Management AB's 96 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 18.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PRGO | Buy | Perrigo Co Plc | $20,982,000 | +105.2% | 145,000 | +123.1% | 3.17% | +94.6% |
| ABMD | Buy | Abiomed Inc | $19,862,000 | +181.7% | 220,000 | +189.5% | 3.00% | +167.2% |
| MDT | Sell | Medtronic Plc | $19,153,000 | +8.0% | 249,000 | -6.0% | 2.90% | +2.4% |
| ALXN | Sell | Alexion Pharmaceuticals Inc | $19,075,000 | +6.1% | 100,000 | -13.0% | 2.88% | +0.6% |
| CVS | Buy | CVS Health Corp | $17,599,000 | +88.0% | 180,000 | +85.6% | 2.66% | +78.4% |
| AGN | Buy | Allergan Plc | $17,188,000 | +37.5% | 55,000 | +19.6% | 2.60% | +30.4% |
| ABBV | Buy | AbbVie Inc | $14,573,000 | +27.5% | 246,000 | +17.1% | 2.20% | +20.9% |
| UNH | Sell | United Health Group Inc | $14,234,000 | -16.5% | 121,000 | -17.7% | 2.15% | -20.9% |
| PFE | Buy | Pfizer Inc | $14,139,000 | +6.9% | 438,000 | +4.0% | 2.14% | +1.4% |
| AMGN | Sell | Amgen Inc | $13,311,000 | -28.7% | 82,000 | -39.3% | 2.01% | -32.4% |
| CI | Sell | Cigna Corp | $12,731,000 | -11.0% | 87,000 | -17.8% | 1.92% | -15.6% |
| BMY | Sell | Bristol Myers Squibb Co | $12,589,000 | +10.8% | 183,000 | -4.7% | 1.90% | +5.0% |
| GILD | Buy | Gilead Sciences Inc | $12,548,000 | +11.1% | 124,000 | +7.8% | 1.90% | +5.4% |
| ALKS | Sell | Alkermes Plc | $12,542,000 | -16.2% | 158,000 | -38.0% | 1.90% | -20.5% |
| CELG | Sell | Celgene Corp | $12,455,000 | -15.3% | 104,000 | -23.5% | 1.88% | -19.7% |
| BMRN | Buy | BioMarin Pharmaceutical Inc | $12,362,000 | +36.5% | 118,000 | +37.2% | 1.87% | +29.4% |
| LLY | Sell | Eli Lilly & Co | $12,302,000 | -20.5% | 146,000 | -21.1% | 1.86% | -24.6% |
| ANTM | Sell | Anthem Inc | $12,271,000 | -18.1% | 88,000 | -17.8% | 1.86% | -22.3% |
| INCY | Buy | Incyte Corp Ltd | $11,930,000 | -0.8% | 110,000 | +0.9% | 1.80% | -5.9% |
| MCK | Sell | McKesson Corp | $11,637,000 | -18.3% | 59,000 | -23.4% | 1.76% | -22.5% |
| REGN | Buy | Regeneron Pharmaceuticals Inc | $11,400,000 | +48.5% | 21,000 | +27.3% | 1.72% | +40.8% |
| AET | Sell | Aetna Inc | $11,244,000 | -25.5% | 104,000 | -24.6% | 1.70% | -29.4% |
| WBA | New | Walgreens Boots Alliance Inc | $11,240,000 | – | 132,000 | +100.0% | 1.70% | – |
| ZBH | Buy | Zimmer Biomet Hgs Inc | $10,977,000 | +67.0% | 107,000 | +52.9% | 1.66% | +58.4% |
| HUM | Sell | Humana Inc | $10,889,000 | -24.0% | 61,000 | -23.8% | 1.65% | -27.9% |
| STJ | Sell | St Jude Medical Inc | $10,810,000 | -9.8% | 175,000 | -7.9% | 1.63% | -14.5% |
| BDX | Sell | Becton Dickinson & Co | $10,632,000 | -11.9% | 69,000 | -24.2% | 1.61% | -16.5% |
| LH | Laboratory Corp of America Hgs | $10,015,000 | +14.0% | 81,000 | 0.0% | 1.51% | +8.1% | |
| CNC | Sell | Centene Corp | $9,806,000 | +3.3% | 149,000 | -14.9% | 1.48% | -2.0% |
| NKTR | Sell | Nektar Therapeutics | $9,790,000 | +29.8% | 581,000 | -15.6% | 1.48% | +23.1% |
| CAH | Sell | Cardinal Health Inc | $9,284,000 | -24.0% | 104,000 | -34.6% | 1.40% | -27.9% |
| DXCM | Buy | Dexcom Inc | $8,600,000 | +19.2% | 105,000 | +25.0% | 1.30% | +13.0% |
| HNT | Sell | Health Net Inc | $8,352,000 | -7.5% | 122,000 | -18.7% | 1.26% | -12.3% |
| MDVN | Buy | Medivation Inc | $7,734,000 | +59.6% | 160,000 | +40.4% | 1.17% | +51.4% |
| ENDP | Buy | Endo International Plc | $7,102,000 | +40.4% | 116,000 | +58.9% | 1.07% | +33.3% |
| HALO | Buy | Halozyme Therapeutics Inc | $7,105,000 | +207.6% | 410,000 | +138.4% | 1.07% | +191.8% |
| VRTX | Sell | Vertex Pharmaceuticals Inc | $7,046,000 | -35.6% | 56,000 | -46.7% | 1.06% | -38.9% |
| CEMP | Sell | Cempra Inc | $7,035,000 | -15.2% | 226,000 | -24.2% | 1.06% | -19.6% |
| VRX | New | Valeant Pharm Intl Inc | $7,014,000 | – | 69,000 | +100.0% | 1.06% | – |
| ITCI | Sell | Intra-Cellular Therapies Inc | $6,778,000 | +2.6% | 126,000 | -23.6% | 1.02% | -2.7% |
| HCA | Sell | HCA Holdings Inc | $6,492,000 | -53.4% | 96,000 | -46.7% | 0.98% | -55.8% |
| ESRX | Sell | Express Scripts Hg Co | $6,468,000 | -16.8% | 74,000 | -22.9% | 0.98% | -21.1% |
| KERX | Sell | Keryx Biopharmaceuticals Inc | $6,227,000 | +13.2% | 1,233,000 | -21.1% | 0.94% | +7.3% |
| RVNC | Buy | Revance Therapeutics Inc | $5,910,000 | +34.2% | 173,000 | +16.9% | 0.89% | +27.4% |
| JAZZ | Sell | Jazz Pharmaceuticals Plc | $5,904,000 | -4.8% | 42,000 | -10.1% | 0.89% | -9.7% |
| ALNY | Sell | Alnylam Pharmaceuticals Inc | $5,837,000 | -4.4% | 62,000 | -18.4% | 0.88% | -9.3% |
| RAD | Buy | Rite Aid Corp | $5,316,000 | +31.7% | 678,000 | +2.0% | 0.80% | +24.8% |
| UHS | Sell | Universal Health Services Inc B | $5,258,000 | -13.8% | 44,000 | -10.0% | 0.80% | -18.3% |
| BSX | New | Boston Scientific Corp | $5,053,000 | – | 274,000 | +100.0% | 0.76% | – |
| CLDX | Buy | Celldex Therapeutics Inc | $5,018,000 | +61.4% | 320,000 | +8.5% | 0.76% | +53.0% |
| COO | Buy | Cooper Companies Inc (The) | $4,965,000 | +1.1% | 37,000 | +12.1% | 0.75% | -4.1% |
| CERN | Sell | Cerner Corp | $4,934,000 | -29.1% | 82,000 | -29.3% | 0.75% | -32.7% |
| ABC | Sell | AmerisourceBergen Corp | $4,771,000 | -20.3% | 46,000 | -27.0% | 0.72% | -24.4% |
| LBIO | Sell | Lion Biotechnologies Inc | $4,439,000 | +12.8% | 575,000 | -15.8% | 0.67% | +7.0% |
| ACAD | Sell | Acadia Pharmaceuticals Inc | $4,278,000 | -34.0% | 120,000 | -38.8% | 0.65% | -37.4% |
| ELGX | Buy | Endologix Inc | $4,158,000 | +48.1% | 420,000 | +83.4% | 0.63% | +40.4% |
| IONS | New | Ionis Pharmaceuticals Inc | $4,149,000 | – | 67,000 | +100.0% | 0.63% | – |
| LIVN | New | Livanova Plc | $3,918,000 | – | 66,000 | +100.0% | 0.59% | – |
| ICPT | Sell | Intercept Pharmaceuticals Inc | $3,883,000 | -26.8% | 26,000 | -18.8% | 0.59% | -30.6% |
| SUPN | Sell | Supernus Pharmaceuticals Inc | $3,871,000 | -21.9% | 288,000 | -18.5% | 0.58% | -25.9% |
| EW | Sell | Edwards Lifesciences Corp | $3,870,000 | -56.1% | 49,000 | -21.0% | 0.58% | -58.4% |
| ZLTQ | Sell | ZELTIQ Aesthetics Inc | $3,652,000 | -27.4% | 128,000 | -18.5% | 0.55% | -31.2% |
| PODD | Sell | Insulet Corp | $3,630,000 | +27.4% | 96,000 | -12.7% | 0.55% | +20.9% |
| BXLT | New | Baxalta Inc | $3,435,000 | – | 88,000 | +100.0% | 0.52% | – |
| HTWR | Sell | Heartware Intl Inc | $3,377,000 | -25.8% | 67,000 | -23.0% | 0.51% | -29.6% |
| PTLA | Sell | Portola Pharmaceuticals Inc | $3,190,000 | +5.4% | 62,000 | -12.7% | 0.48% | 0.0% |
| HZNP | New | Horizon Pharma Plc | $3,164,000 | – | 146,000 | +100.0% | 0.48% | – |
| MGNX | Sell | Macrogenics Inc | $2,911,000 | +25.9% | 94,000 | -12.9% | 0.44% | +19.2% |
| ACHN | Sell | Achillion Pharmaceuticals Inc | $2,870,000 | +48.3% | 266,000 | -5.0% | 0.43% | +40.9% |
| CPHD | Buy | Cepheid Inc | $2,740,000 | +18.9% | 75,000 | +47.1% | 0.41% | +12.8% |
| ARIA | Ariad Pharmaceuticals Inc | $2,688,000 | +7.0% | 430,000 | 0.0% | 0.41% | +1.5% | |
| PCRX | New | Pacira Pharmaceuticals Inc | $2,688,000 | – | 35,000 | +100.0% | 0.41% | – |
| TSRO | Tesaro Inc | $2,663,000 | +30.5% | 50,899 | 0.0% | 0.40% | +24.0% | |
| XNCR | Xencor Inc | $2,651,000 | +19.6% | 181,303 | 0.0% | 0.40% | +13.6% | |
| EXEL | New | Exelixis Inc | $2,594,000 | – | 460,000 | +100.0% | 0.39% | – |
| RIGL | Sell | Rigel Pharmaceuticals Inc | $2,558,000 | +11.9% | 844,313 | -8.7% | 0.39% | +6.3% |
| CLVS | Buy | Clovis Oncology Inc | $2,555,000 | -35.4% | 73,000 | +69.8% | 0.39% | -38.7% |
| CYH | Sell | Community Health Syst Inc | $2,520,000 | -73.2% | 95,000 | -56.8% | 0.38% | -74.6% |
| TNDM | Tandem Diabetes Care Inc | $2,468,000 | +34.1% | 209,000 | 0.0% | 0.37% | +27.3% | |
| CATB | Buy | Catabasis Pharmaceuticals Inc | $2,428,000 | -0.1% | 306,227 | +1.9% | 0.37% | -5.2% |
| SGNT | New | Sagent Pharmaceuticals Inc | $2,387,000 | – | 150,000 | +100.0% | 0.36% | – |
| OMCL | Omnicell Inc | $2,300,000 | -0.0% | 74,000 | 0.0% | 0.35% | -5.2% | |
| CMRX | Buy | Chimerix Inc | $2,291,000 | +7.1% | 256,000 | +357.1% | 0.35% | +1.5% |
| TTPH | Tetraphase Pharmaceuticals Inc | $2,257,000 | +34.4% | 225,000 | 0.0% | 0.34% | +27.2% | |
| ESPR | Esperion Therapeutics Inc | $2,226,000 | -5.6% | 100,000 | 0.0% | 0.34% | -10.4% | |
| OREX | Orexigen Therapeutics Inc | $2,045,000 | -18.5% | 1,189,000 | 0.0% | 0.31% | -22.8% | |
| RGLS | Regulus Therapeutic Inc | $1,744,000 | +33.3% | 200,000 | 0.0% | 0.26% | +26.3% | |
| MRTX | Mirati Therapeutics Inc | $1,580,000 | -8.2% | 50,000 | 0.0% | 0.24% | -12.8% | |
| ARRY | Array BioPharma Inc | $1,561,000 | -7.5% | 370,000 | 0.0% | 0.24% | -12.3% | |
| FGEN | New | FibroGen Inc | $1,524,000 | – | 50,000 | +100.0% | 0.23% | – |
| AAVL | Avalanche Biotechnologies Inc | $1,466,000 | +15.5% | 154,006 | 0.0% | 0.22% | +9.9% | |
| DVAX | Dynavax Technologies Corp | $1,329,000 | -1.6% | 55,000 | 0.0% | 0.20% | -6.5% | |
| HOLX | Hologic Inc | $1,288,000 | -1.2% | 33,301 | 0.0% | 0.20% | -6.2% | |
| ANTH | Anthera Pharmaceuticals Inc | $1,160,000 | -23.8% | 250,000 | 0.0% | 0.18% | -28.0% | |
| BINDQ | BIND Therapeutics Inc | $306,000 | -48.7% | 133,535 | 0.0% | 0.05% | -51.6% | |
| THLD | Threshold Pharmaceuticals | $97,000 | -88.2% | 201,537 | 0.0% | 0.02% | -88.5% | |
| LXRX | Exit | Lexicon Pharmaceuticals Inc | $0 | – | -200,000 | -100.0% | -0.34% | – |
| KITE | Exit | Kite Pharma Inc | $0 | – | -57,000 | -100.0% | -0.51% | – |
| ISIS | Exit | Isis Pharmaceuticals Inc | $0 | – | -80,000 | -100.0% | -0.52% | – |
| CYBX | Exit | Cyberonics Inc | $0 | – | -57,000 | -100.0% | -0.55% | – |
| MYL | Exit | Mylan N.V. | $0 | – | -100,000 | -100.0% | -0.64% | – |
| MRK | Exit | Merck & Co Inc | $0 | – | -100,000 | -100.0% | -0.79% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-01-19
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITEDHEALTH GROUP INC | 40 | Q3 2023 | 4.0% |
| BIOMARIN PHARMACEUTICAL INC | 40 | Q3 2023 | 5.0% |
| ALKERMES PLC | 40 | Q3 2023 | 3.3% |
| LILLY ELI & CO | 39 | Q3 2023 | 5.8% |
| CVS HEALTH CORP | 39 | Q3 2023 | 3.5% |
| INTRA-CELLULAR THERAPIES INC | 39 | Q3 2023 | 2.4% |
| EDWARDS LIFESCIENCES CORP | 39 | Q3 2023 | 1.7% |
| VERTEX PHARMACEUTICALS INC | 38 | Q3 2023 | 4.3% |
| REVANCE THERAPEUTICS INC | 38 | Q3 2023 | 0.9% |
| ABBVIE INC | 37 | Q3 2023 | 4.4% |
View Rhenman & Partners Asset Management AB's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR/A | 2023-11-13 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Rhenman & Partners Asset Management AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.